Sign In
 
LoginPassword Help
 
Username:
Password:
 

Support the Special Diabetes Program's Research and Programs!

The Special Diabetes Program (SDP) and the Special Diabetes Program for Indians (SDPI) are critical to managing and ultimately curing diabetes. Now, these programs needed to be renewed by Congress, and we know that a 5-year reauthorization has bipartisan support and will be especially critical during the COVID-19 pandemic, which disproportionately impacts people with diabetes. Help us lock-in a more certain future for these vital programs!  

Why do you care about type 1 diabetes research, and/or type 2 diabetes prevention among Native Americans? Personalizing your letter is important.

 

Recipients

  • Your Senators
  • Your Representative

Contact

*Required fields
 
 

Message

Renew the Special Diabetes Program Today!

Dear [Decision Maker],

The Special Diabetes Program (SDP) and the Special Diabetes Program for Indians (SDPI) play an instrumental role in improving the lives of the 122 million Americans with diabetes or prediabetes. SDP and SDPI are special statutory funding programs charged with researching the prevention and cure of type 1 diabetes, with SDPI paying special attention to the diabetes epidemic in American Indian and Alaska Native communities. Operating out of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Indian Health Service (IHS) respectively, the programs have enabled clinical trials, created research consortia, and generated numerous resources that are critical to scientists, allowing for groundbreaking discoveries.



These efforts are especially critical given the disproportionate impact that COVID-19 has on people with diabetes. 40% of American COVID-19 victims have diabetes, though the condition affects just 10% of the U.S. population. Additionally, Americans with diabetes and other related underlying health conditions are hospitalized 6 times more often and are 12 times more likely to die of COVID-19 than those without. These outcomes and infection rates are disproportionately higher in Black, Indigenous, and people of color (BIPOC) communities. In fact, the COVID-19 mortality rate for Indigenous Americans is 3.4 times as high as compared to White Americans. Given these stark figures, it is essential that resources be reliably allotted to efforts to combat diabetes. A long-term reauthorization of the Special Diabetes Program will be a significant boost to the Americans impacted by diabetes, and we need it now more than ever.

Sincerely,
[Your Name]
[Your Address]
[City, State ZIP]
[Your Email]